Clinical Trial: SGN-PDL1V

Trial Status: Open
Sponsor ID SGNPDL1V-001

A Phase 1 Study of SGN-PDL1V in Advanced Solid Tumors


Fairfax Office

Learn More About This Trial
Other Relevant Trials
Trial ID TAK-981-1502
Sponsor ID Takeda Oncology

Phase 1b/2 Study of TAK-981 Plus Pembrolizumab to Evaluate the Safety, Tolerability, and Antitumor Activity of the Combination in Patients With Select Advanced or Metastatic Solid Tumors

1 Location
Trial ID M20-111
Sponsor ID AbbVie

“A Phase 1 first in human study evaluating safety and efficacy of ABBV-637 as either monotherapy or in combination in adult subjects with relapsed and refractory solid tumors”

1 Location